Abstract:High intensity focused ultrasound (HIFU) has attracted the great attention in tumor ablation due to its non-invasive, efficient and economic features. However, HIFU ablation has its intrinsic limitations for removing the residual tumor cells, thus the tumor recurrence and metastasis cannot be avoided in this case. Herein, we developed a multifunctional targeted poly(lactic-co-glycolic acid) (PLGA) nanobubbles (NBs), which not only function as an efficient ultrasound contrast agent for tumor imaging, but also a targeted anticancer drug carrier and excellent synergistic agent for enhancing the therapeutic efficiency of HIFU ablation. Methotrexate (MTX)-loaded NBs were synthesized and filled with perfluorocarbon gas subsequently using a facile but general double emulsion evaporation method. The active tumor-targeting monoclonal anti-HLA-G antibodies (mAbHLA-G) were further conjugated onto the surface of nanobubbles. The mAbHLA-G/MTX/PLGA NBs could enhance the ultrasound imaging both in vitro and in vivo, and the targeting efficiency to HLA-G overexpressing JEG-3 cells has been demonstrated. The elaborately designed mAbHLA-G/MTX/PLGA NBs can specifically target to the tumor cells both in vitro and in vivo, and their blood circulation time in vivo was much longer than non-targeted MTX/PLGA NBs. Further therapeutic evaluations showed that the targeted NBs as a synergistic agent can significantly improve the efficiency of HIFU ablation by changing the acoustic environment, and the focused ultrasound can promote the on-demand MTX release both in vitro and in vivo. The in vivo histopathology test and immunohistochemical analysis showed that the mAbHLA-G/MTX/PLGA NBs plus HIFU group presented most serious coagulative necrosis, the lowest proliferation index and the highest apoptotic index. Therefore, the successful introduction of targeted mAbHLA-G/MTX/PLGA NBs provides an excellent platform for the highly efficient, imaging-guided and non-invasive HIFU synergistic therapy of cancer with the supplementary functions of killing residual tumor cells and preventing tumor recurrence/metastasis.

Hematoporphyrin Encapsulated PLGA Microbubble for Contrast Enhanced Ultrasound Imaging and Sonodynamic Therapy.

Small PLGA Nanocapsules Co-encapsulating Copper Sulfide Nanodots and Fluorocarbon Compound for Photoacoustic Imaging-Guided HIFU Synergistic Therapy

Nano/Microparticles And Ultrasound Contrast Agents

Perfluoropentane-encapsulated Hollow Mesoporous Prussian Blue Nanocubes for Activated Ultrasound Imaging and Photothermal Therapy of Cancer.

Preparation of Hematoporphyrin-Poly(Lactic Acid) Nanoparticles Encapsulated Perfluoropentane/Salicylic Acid for Enhanced US/CEST MR Bimodal Imaging

Biodegradable Double-Targeted Ptx-Mpeg-Plga Nanoparticles for Ultrasound Contrast Enhanced Imaging and Antitumor Therapy in Vitro

Multifunctional Microbubbles and Nanobubbles for Photoacoustic and Ultrasound Imaging

Hollow Periodic Mesoporous Organosilicas Nanoparticles for Efficient Ultrasound-Based Imaging and Ultrasound-Mediated Therapy

SPIO nanoparticle-stabilized PAA-F127 thermosensitive nanobubbles with MR/US dual-modality imaging and HIFU-triggered drug release for magnetically guided in vivo tumor therapy.

Multi-functional Ultrasound Contrast Agents for in Vitro Ultrasound/mr Dual-Mode Imaging and High-Intensity Focused Ultrasound Synergism

Ultrasound Contrast-Enhanced Imaging and in Vitro Antitumor Effect of Paclitaxel-Poly(lactic-co-glycolic Acid)-Monomethoxypoly (ethylene Glycol) Nanocapsules with Ultrasound-Targeted Microbubble Destruction

Dual Ph- and Glutathione-Responsive CO2-Generating Nanodrug Delivery System for Contrast-Enhanced Ultrasonography and Therapy of Prostate Cancer

Organic-Inorganic Hybrid Hollow Mesoporous Organosilica Nanoparticles for Efficient Ultrasound-Based Imaging and Controlled Drug Release

Superparamagnetic PLGA-iron Oxide Microcapsules for Dual-Modality US/MR Imaging and High Intensity Focused US Breast Cancer Ablation

Lactoferrin-Conjugated Polylactic Acid Nanobubbles Encapsulated Perfluoropentane as a Contrast Agent for Ultrasound/Magnetic Resonance Dual-Modality Imaging

Methotrexate-Loaded Plga Nanobubbles for Ultrasound Imaging and Synergistic Targeted Therapy of Residual Tumor During Hifu Ablation

Doxorubicin Loaded Superparamagnetic PLGA-iron Oxide Multifunctional Microbubbles for Dual-Mode US/MR Imaging and Therapy of Metastasis in Lymph Nodes

Superparamagnetic PLGA–iron oxide microspheres as contrast agents for dual-imaging and the enhancement of the effects of high-intensity focused ultrasound ablation on liver tissue

Graphene oxide modified PLA microcapsules containing gold nanoparticles for ultrasonic/CT bimodal imaging guided photothermal tumor therapy.

Temperature-controlled, phase-transition ultrasound imaging-guided photothermal-chemotherapy triggered by NIR light

GE11-PDA-Pt@USPIOs Nano-Formulation for Relief of Tumor Hypoxia and MRI/PAI-guided Tumor Radio-Chemotherapy